BDMC negatively regulates the Wnt/β-catenin pathway by elevating WIF-1 expression, which subsequently blocks TGF-β1-induced EMT to inhibit migration and invasion in highly metastatic NSCLC [143]. This evidence concerns the gene WIF1 and non-small cell lung carcinoma.